AGXT p.Ser218=
c.654G>A · rs33958047 · VCV198034
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -8.7 | GERP -2.2 |
| Overall | ||
| CADD | 0.068 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 20% | 5 |
| East Asian | 15.7% | 6 |
| South Asian | 12.2% | 8 |
| Remaining individualsnot grpmax-eligible | 11.7% | 9 |
| Middle Eastern | 11.6% | 9 |
| European (non-Finnish) | 10.3% | 10 |
| Ashkenazi Jewishnot grpmax-eligible | 9.48% | 11 |
| Finnishnot grpmax-eligible | 8.83% | 11 |
| Admixed American | 5.85% | 17 |
| Amishnot grpmax-eligible | 4.18% | 24 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- AGXT
- Protein
- p.Ser218=
- Coding
- c.654G>A
- MANE Select
- NM_000030
- dbSNP
- rs33958047
- Type
- single nucleotide variant
- Location
- chr2:240874036 (GRCh38)
- Gene constraint
- LOEUF 1.251 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 98.30 · 17 PDB
- Residue 218
- a UniProt-annotated variant site (in hp1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; no effect on protein stability); a β-strand
Disease context
primary hyperoxaluria type 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Primary hyperoxaluria (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- All ages
- Prevalence
- 1-9 / 1 000 000 (Germany)
Similar variants
- AGXT p.Ser218Leu Pathogenic ★★ same residue
- AGXT p.Ser218Ter Likely pathogenic ★ same residue
- AGXT c.358+1G>A Pathogenic ★★ same condition
- AGXT c.359-2A>G Likely pathogenic ★★ same condition
- AGXT c.423+1G>A Pathogenic/Likely pathogenic ★★ same condition
- AGXT c.524+2T>A Likely pathogenic ★★ same condition
- AGXT c.525-1G>A Pathogenic ★★ same condition
- AGXT c.525-2A>T Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/agxt-p-ser218 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown